| Identification | Back Directory | [Name]
L-Glutamic acid, N-[4-[4-(2-amino-3,4-dihydro-4-oxo-5H-pyrrolo[3,2-d]pyrimidin-5-yl)butyl]-2-fluorobenzoyl]- | [CAS]
2294820-23-6 | [Synonyms]
L-Glutamic acid, N-[4-[4-(2-amino-3,4-dihydro-4-oxo-5H-pyrrolo[3,2-d]pyrimidin-5-yl)butyl]-2-fluorobenzoyl]- | [Molecular Formula]
C22H24FN5O6 | [MOL File]
2294820-23-6.mol | [Molecular Weight]
473.45 |
| Chemical Properties | Back Directory | [density ]
1.53±0.1 g/cm3(Predicted) | [storage temp. ]
2-8°C | [solubility ]
DMSO: 2mg/L, clear | [form ]
powder | [pka]
3.53±0.10(Predicted) | [color ]
white to beige |
| Hazard Information | Back Directory | [Biological Activity]
AGF347 is a potent inhibitor of serine hydroxymethyltransferase 2 (SHMT2) th at inhibits mitochondrial C1 metabolism. It also inhibits cytosolic C1 targets such as SHMT1GARFTaseand AICARFTase. AGF347 inhibits de novo purine biosynthesis. AGF347 exhibits potent broad spectrum in vitro and in vivo antitumor efficacy. |
|
| Company Name: |
Merck KGaA
|
| Telephone: |
21-20338288 |
| Website: |
www.sigmaaldrich.cn |
|